Optimism pervades Parkinson's conference. by Booker, S M
Over the week of 25–28 August 2001, a
group of great minds thought alike in
Colorado Springs, Colorado—epidemiolo-
gists, neurologists, and scientists from
many other fields gathered to review the
state of the science regarding Parkinson’s
disease (PD). 
The conference was sponsored by the
University of Arkansas for Medical
Sciences and supported by numerous pri-
vate and federal research facilities includ-
ing the NIEHS. The participants came
with a great sense of anticipation and
hope, as recent research has given a new
boost to the study of PD. Donato Di
Monte, director of basic research at the
nonprofit Parkinson’s Institute of
Sunnyvale, California, and a conference
cochair, put it this way: “We’re no longer
at a stage where we wonder whether to
look at environment or look at genes. . . .
In a few years we might be able to come
together and be talking about real issues
like how to implement these ideas in pre-
vention and treatment.”
A Multifaceted Brain Disorder
Because the conference was attended by
scientists from many different disciplines
tackling PD from many different angles,
several speakers reviewed the chemical,
biopathologic, epidemiologic, toxicologic,
and neurologic aspects of PD. PD is just
one of many similar disorders grouped
under the name “parkinsonism.” Sufferers
may have tremor in their limbs, jaw, or
face, and rigidity in their limbs and torso.
They may move slowly with jerky motions
and suffer impaired balance and coordina-
tion. PD is a progressive disorder that most
often begins after age 55. It is incurable.
However, symptoms can sometimes be
treated with drugs such as L-dopa or with
treatments such as deep brain stimulation,
in which an electrode is implanted in the
brain in order to standardize the electric
current fueling the brain’s different
processes. 
PD symptoms are caused by the loss of
cells in the substantia nigra, a part of the
brain that controls movement. Nigral cells
produce the neurotransmitter dopamine,
and dopamine controls signalling to the
motor cortex, which initiates smooth
movement. Once dopamine has been
depleted by about 80%, the jerky, uncon-
trolled movements characteristic of PD
begin to appear. It is not yet known
whether PD patients are born with less
dopamine, whether dopamine loss acceler-
ates with age, or whether loss is secondary
to some other process.
Postmortem examinations also reveal
that PD patients typically develop Lewy
bodies, microscopic structures containing
the protein α-synuclein, in the substantia
nigra. Scientists still aren’t sure what role
Lewy bodies play in PD. It is possible that
they cause cell death, or that they serve as
corrals, concentrating toxicants in the
brain. Whether they cause PD or are
caused by PD is unknown.
Interest in PD as a possible environ-
ment-related disease grew after the publica-
tion of a paper by Parkinson’s Institute
researcher Caroline Tanner and colleagues
in the 27 January 1999 issue of the Journal
of the American Medical Association.
Tanner’s results showed that fraternal and
identical twins did not show appreciably
different concordance rates of PD. As
genetics did not appear to be driving the
disease, the researchers suspected there is a
strong environmental component.
Although, as Di Monte said at the con-
ference, “aging is the only unequivocal risk
factor for PD,” several environmental fac-
tors correlate with PD incidence. These
include exposure to hydrocarbon solvents,
viral infections such as encephalitis, high
dietary fat, high iron levels, depression,
and head injury. Exposure to both single
metals such as manganese and to mixtures
of metals including lead, copper, and iron
has also been implicated.
Pesticides have long been suspected of
having a particularly strong link with PD.
A 2000 study by Lorene Nelson of
Stanford University, with colleagues
Tanner and Stephen Van Den Eeden of
the Kaiser Permanente Medical Care
Program of Northern California, showed a
70% increased risk of PD among users of
in-home insecticide and garden herbicides.
(No dose–response relationship was clari-
fied.) These findings were presented at the
2000 annual meeting of the American
Academy of Neurology in San Diego,
California. The widely used paraquat,
maneb, and heptachlor have been especial-
ly targeted as pesticides implicated in PD,
and paraquat and maneb in combination
have been shown in mouse studies to cause
greater locomotor disturbance than either
pesticide by itself.
Other studies have demonstrated an
inverse correlation between certain envi-
ronmental agents and PD incidence, sug-
gesting the possibility of neuroprotective
effects. Several of these agents involve so-
called vice behaviors. Over 35 case–control
studies—including prospective studies,
where recall bias is not an issue—have
shown that the risk of PD is lower in
smokers than in nonsmokers. Smoking
can also reduce many of the symptoms
of PD. Other studies have shown that
caffeine boosts the effects of L-dopa in
laboratory animals, and that drinking
beer and spirits (but not wine) corre-
lates with a 30–40% reduced incidence
of PD.
Intriguing theories about the possi-
ble connection between PD and vice
behaviors abound. Perhaps people
who are predisposed to PD are also
predisposed to avoid high-risk or plea-
surable behaviors, such as smoking.
Animal studies have already shown
that dopamine depletion leads to
decreased exploratory behavior.
Similarly, lower brain dopamine con-
centrations in people predisposed to
developing PD might lead to a
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Pinpointing PD. Parkinson’s disease symptoms are caused by the loss of cells in the substantia nigra (in
red), a part of the brain that controls movement.
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Preduced propensity for novel or pleasur-
able behaviors, so that they would smoke
or drink less than others. This would
make it appear that smoking and alcohol
use protects against PD—which may or
may not be the case. 
Vice behaviors do not have a monopoly
on lowering risk, however. Vitamin E and
other dietary antioxidants also have been
associated with lowered incidence. The
effect is noted in legumes containing these
compounds, however, rather than in
dietary supplements. Another study, in
Germany, found no correlation between
vitamin E and PD, but did note lowered
risk with intake of niacin, beta carotene,
and ascorbic acid. (Niacin is also found in
coffee.)
Defining a Course of Action
Specific research directions identified at
the conference include identifying specific
gene mutations—perhaps, for example, of
the α-synuclein gene—to yield a PD-vul-
nerable phenotype. Defining the role of
the Lewy body in PD is another important
step. “Ultimately a combined approach
utilizing a highly interactive interplay
between epidemiology, genetics, and basic
science will be required to unravel the
cause of PD,” said keynote speaker J.
William Langston, founder and president
of the Parkinson’s Institute.
Participants discussed where research
dollars could be spent most effectively in
PD research. Suggestions included looking
for clinical pathologic symptoms of PD,
gene profiling, studying the cellular mech-
anisms behind neurodegeneration, build-
ing well-characterized brain banks, using
microarray technology, and sharing data
and resources.
Epidemiologic studies are critical for
identifying risk factors for PD that can
then be studied in animal models. But
such studies are difficult because the disor-
der is relatively rare—according to the
Parkinson’s Institute, it afflicts about 200
out of every 100,000 people. There is no
registry for PD cases, and PD is rarely listed
on death certificates as a cause of death.
There is currently no diagnostic test or bio-
marker that can be measured for living
patients, and the long preclinical period
means many people who are in fact affected
may die before they show PD symptoms.
Finally, PD is usually a late-life disorder,
and identifying possible relevant environ-
mental exposures has to date been necessar-
ily retrospective.
Some of these difficulties are being
addressed in a study described at the con-
ference by NIEHS epidemiologist Freya
Kamel, Tanner, and colleagues. Kamel
and Tanner will perform a nested
case–control study to prospectively
examine the epidemiology of PD
among farmers who are already par-
ticipating in the ongoing Agri-
cultural Health Study. Several earli-
er studies looked at agricultural
work and PD among general popu-
lations, but this study has the advan-
tage of studying the disorder in a
population with more consistent
exposure to potential PD risk factors
such as pesticide use. The
researchers will take detailed infor-
mation on the subjects’ pesticide
use, life style, and health status.
Subjects will also undergo a neuro-
logic evaluation and pesticide and
metal blood assays, and mutations
in their DNA will be studied. In
addition, the researchers will look
for the presence of the soil microbe
Nocardia asteroides, which has been
shown to induce parkinsonian
symptoms in lab animals.
Many other questions wait to be
answered. Why do more men devel-
op PD? Is it a hormonally related
disorder? Is it X-linked? Or are occu-
pational exposures to blame? A study
of PD cases in Olmsted County,
Minnesota, showed a sharp spike in
cases among women during the years
1945–1954 and a more gradual
increase after 1964. Might this be
due to women’s changing role in the
workplace since World War II? Why
do PD rates differ among white, black,
and Asian populations? And what is it
about aging that makes it such a promi-
nent risk factor for PD? 
NIEHS Goes a Step Further
The NIEHS currently supports 24 PD-
related research projects through its extra-
mural Environmental Health Sciences
Centers Program. At the beginning of the
conference, Olden announced that the
institute is going a step further by establish-
ing a consortium to study gene–environ-
ment interactions in PD. By learning more
about how environmental exposures and
genetic predisposition work together to
cause PD, scientists can begin to develop
effective approaches to disease prevention,
diagnosis, and treatment. Olden hopes the
consortium will be funded by the end of
fiscal year 2002; a request for applications
was in the process of being released at the
end of November. Eventually the consor-
tium will include other federal agencies as
well as private research organizations.
The consortium is intended to extend
and integrate existing funded research in
PD, increase communication among clini-
cans, geneticists, epidemiologists, and basic
science researchers in the field of PD, and
support the translation of research findings
from the laboratory to the clinical setting.
By enhancing communication among sci-
entists with similar goals, promising lines
of investigation can be identified and pur-
sued more promptly and effectively, and
granting agencies can respond more quick-
ly to research opportunities as they arise.
“Once we agree on concept and scope,”
said Olden, “we can develop a more
detailed strategic plan that includes budget
and time lines.” 
In the meantime, the conference has
provided a solid starting point for future
collaborations. Said Olden, “The science
and interaction between scientists [at the
conference] has been outstanding.
Typically people listen, and you have one
or two questions, but here there has been
lots of discussion. The science has already
come a long way. If we can start working
on some of the points raised here, I hope
we can start making some progress in the
next three to four years.” –Susan M. Booker
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NIEHS and ACC Establish
Grant Program
On 26 July 2001 the NIEHS and the
American Chemistry Council (ACC) signed
a unique memorandum of understanding
that will provide $4 million over the next
two years to conduct multidisciplinary
extramural research on potential develop-
mental toxicants. The research will specifi-
cally study mechanisms of action, using
tools such as DNA microarrays and geneti-
cally sensitized animal models to look at
cellular networks of responding genes,
help define important target molecules
and pathways for toxicity investigations,
and provide clues to future biomarkers of
toxic exposure and effect. Says NIEHS
director Kenneth Olden, “This [memoran-
dum of understanding] is a collaboration
between government and industry to
improve the health of the American peo-
ple by improving the quantity and quality
of the data on potential developmental
toxicants that are available for use in the
risk assessment process.”
The ACC, a chemical industry trade
group, will provide funding for the
grants through its Long-Range Research
Initiative program, established in 1999 to
study the effects of chemicals on humans
and wildlife.
The joint NIEHS–ACC grant program is
expected to fund about 15 exploratory
research grants by next spring.